Your browser doesn't support javascript.
loading
Data-Driven Discovery of Immune Contexture Biomarkers.
Schwen, Lars Ole; Andersson, Emilia; Korski, Konstanty; Weiss, Nick; Haase, Sabrina; Gaire, Fabien; Hahn, Horst K; Homeyer, André; Grimm, Oliver.
Afiliación
  • Schwen LO; Fraunhofer Institut für Bildgestützte Medizin, Bremen, Germany.
  • Andersson E; Pathology and Tissue Analytics, Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany.
  • Korski K; Pathology and Tissue Analytics, Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany.
  • Weiss N; Fraunhofer Institut für Bildgestützte Medizin, Lübeck, Germany.
  • Haase S; Fraunhofer Institut für Bildgestützte Medizin, Bremen, Germany.
  • Gaire F; Pathology and Tissue Analytics, Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany.
  • Hahn HK; Fraunhofer Institut für Bildgestützte Medizin, Bremen, Germany.
  • Homeyer A; Fraunhofer Institut für Bildgestützte Medizin, Bremen, Germany.
  • Grimm O; Pathology and Tissue Analytics, Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany.
Front Oncol ; 8: 627, 2018.
Article en En | MEDLINE | ID: mdl-30619761
ABSTRACT

Background:

Features characterizing the immune contexture (IC) in the tumor microenvironment can be prognostic and predictive biomarkers. Identifying novel biomarkers can be challenging due to complex interactions between immune and tumor cells and the abundance of possible features.

Methods:

We describe an approach for the data-driven identification of IC biomarkers. For this purpose, we provide mathematical definitions of different feature classes, based on cell densities, cell-to-cell distances, and spatial heterogeneity thereof. Candidate biomarkers are ranked according to their potential for the predictive stratification of patients.

Results:

We evaluated the approach on a dataset of colorectal cancer patients with variable amounts of microsatellite instability. The most promising features that can be explored as biomarkers were based on cell-to-cell distances and spatial heterogeneity. Both the tumor and non-tumor compartments yielded features that were potentially predictive for therapy response and point in direction of further exploration.

Conclusion:

The data-driven approach simplifies the identification of promising IC biomarker candidates. Researchers can take guidance from the described approach to accelerate their biomarker research.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2018 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2018 Tipo del documento: Article País de afiliación: Alemania